Increased expression of functional Fas-ligand in activated T cells from patients with systemic lupus erythematosus

Autoimmunity

Volumn 25, Issue 4, 1997, Pages 213-221

  Kovacs, Birgit ^a   Liossis, Stamatis Nick C ^a   Dennis, Gregory J ^b   Tsokos, George C ^a,b  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^b WALTER REED ARMY MEDICAL CENTER   (United States)

Author keywords

Apoptosis; SLE; T cells

Indexed keywords

FAS ANTIGEN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; LYMPHOCYTOTOXICITY; MALE; RHEUMATIC DISEASE; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE;

EID: 0030839580     PISSN: 08916934     EISSN: None     Source Type: Journal    
DOI: 10.3109/08916939708994730     Document Type: Article

References (33)

1. Cohen, J. J. (1993). Apoptosis, Immunol Today, 14, 126-130.
2. Cohen, J. J. (1993). Programmed cell death and apoptosis in lymphocyte development and function, Chest, 103, 99S-101S.
3. Krammer, P. H., Behrmann, I., Daniel, P., Dhein, J. and Debatin, K. M. (1994). Regulation of apoptosis in the immune system, Curr Opin Immunol, 6, 279-289.
4. Green, D. R. and Scott, D. W. (1994). Activation-induced apoptosis in lymphocytes, Curr Opin Immunol, 6, 476-487.
5. Kabelitz, D., Pohl, T. and Pechhold, K. (1993). Activation-induced cell death (apoptosis) of mature peripheral T lymphocytes, Immunol Today, 14, 338-339.
6. Wesselborg, S., Janssen, O. and Kabelitz, D. (1993). Induction of activation-driven death (apoptosis) in activated but not resting peripheral blood T cells, J. Immunol., 150, 4338-4345.
7. Radvanyi, L. G., Mills, G. B. and Miller, R. G. (1993). Religation of the T cell receptor after primary activation of mature T cells inhibits proliferation and induces apoptotic cell death. J. Immunol., 150, 5704-5715.
8. Klas, C., Debatin, K. M., Jonker, R. R. and Krammer, P. H. (1993). Activation interferes with the APO-1 pathway in mature human T cells, Int. Immunol, 5, 625-630.
9. Alderson, M. R., Tough, T. W., Davis-Smith, T., Braddy, S., Falk, B., Schooley, K. A., et al. (1995). Fas ligand mediates activation-induced cell death in human T lymphocytes, J. Exp. Med., 181, 71-77.
10. Ju, S. T., Panka, D. J., Cui, H., Ettinger, R., el-Khatib, M., Sherr, D. H., et al. (1995). Fas (CD95)/FasL interactions required for programmed cell death after T cell activation [see comments], Nature, 373, 444-448.
11. Dhein, J., Walczak, H., Baeumler, C., Debatin, K. M. and Krammer, P. H. (1995). Autocrine T cell suicide mediated by APO-1/(Fas/CD95), Nature, 373, 438-441.
12. Brunner, T., Mogil, R. J., LaFace, D., Yoo, N. J., Mahboubi, A., Echeverri, F. S., et al. (1995). Cell-autonomous Fas(CD95 )/Fas ligand interaction mediates activation-induced apoptosis in T cell hybridomas, Nature, 373, 441-444.
13. Wu, J., Zhou, T., He, J. and Mountz, J. D. (1993). Autoimmune disease in mice due to integration of an endogenous retrovirus in an apoptosis gene, J. Exp. Med., 178, 461-468.
14. Ramsdell, F., Seaman, M. S., Miller, R. E., Tough, T. W., Alderson, M. R. and Lynch, D. H. (1994). gld/gld mice are unable to express a functional ligand for Fas, Eur. J. Immunol., 24, 928-933.
15. Ettinger, R., Wang, J. K., Bossu, P., Pappas, K., Sidman, C. L., Abbas, A. K. and Marshak-Rothstein, A. (1994). Functional distinctions between MRL-1pr and MRL-gld lymphocytes. Normal cells reverse the gld but not the lpr immunoregulatory defect, J. Immunol., 152, 1557-1568.
16. Tsokos, G. C. (1994). Overview of cellular immune function in systemic lupus erythematosus. In: LaHita R. G. ed. Systemic Lupus Erythematosus. (New York: Churchill Livingstone). 13-48.
17. Emlen, W., Niebur, J. and Kadera, R. (1994). Accelerated in vitro apoptosis of lymphocytes from patients with systemic lupus erythematosus, J. Immunol., 152, 3685-3692.
18. Richardson, B. C., Yung, R. L., Johnson, K. J., Rowse, P. E. and Lalwani, N. D. (1996). Monocyte apoptosis in patients with active lupus, Arthritis Rheum, 39, 1432-1434.
19. Aringer, M., Wintersberger, W., Steiner, C. W., Kiener, H., Presterl, E., Jaeger, U., Smolen, J. S. and Graninger, W. B. (1994). High levels of bcl-2 protein in circulating T lymphocytes, but not B lymphocytes, of patients with systemic lupus erythematosus, Arthritis Rheum, 37, 1423-1430.
20. Cheng, J., Zhou, T., Liu, C., Shapiro, J. P., Brauer, M. J., Kiefer, M. C., et al. (1994). Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule, Science, 263, 1759-1762.
21. Mysler, E., Bini, P., Drappa, J., Ramos, P., Friedman, S. M., Krammer, P. H. and Elkon, K. B. (1994). The apoptosis-I/Fas protein in human systemic lupus erythematosus, J. Clin. Invest., 93, 1029-1034.
22. Tan, E. M, Cohen, A. S, Fries, K. F., Masi, A. T., McShane, D. J., Rothfield, N. F., et al. (1982). The 1982 revised criteria for the classification of systemic lupus erythematosus, Arthritis Rheum., 25, 1271.
23. Bombardier, C., Gladman, D. D., Urowitz, M. B., Caron, D. and Chang, C. H. (1992). Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum., 35, 630-640.
24. Kovacs, B. and Tsokos, G. C. (1995). Cross-linking of the Fas/APO-1 antigen suppresses the CD3-mediated signal transduction events in human T lymphocytes, J. Immunol., 155, 5543-5549.
25. Yonehara, S., Nishimura, Y., Kishil, S., Yonehara, M., Takazawa, K., Tamatani, T. and Ishii, A. (1994). Involvement of apoptosis antigen Fas in clonal deletion of human thymocytes, Int. Immunol., 6, 1849-1856.
26. Nagata, S. and Suda, T. Fas and Fas ligand: lpr and gld mutations, Immunol Today, 16, 39-43.
27. Ramsdell, F., Seaman, M. S., Miller, R. E., Tough, T. W., Alderson, M. R. and Lynch, D. H. (1994). gld/gld mice are unable to express a functional ligand for Fas, Eur. J. Immunol, 24, 928-933.
28. Takahashi, T., Tanaka, M., Brannan, C. I., Jenkins, N. A., Copeland, N. G., Suda, T. and Nagata, S. (1994). Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand, Cell, 76, 969-976.
29. Mountz, J. D., Wu, J., Cheng, J. and Zhou, T. (1994). Autoimmune disease. A problem of defective apoptosis, Arthritis Rheum, 37, 1415-1420.
30. Drappa, J., Vaishnaw, A. K., Sullivan, K. E., Chu, J. L. and Elkon, K. B. (1996). Thirty year follow up of humans with Fas mutations, Arthritis Rheum, 39, S217 (Abstract).
31. Amasaki, Y., Kobayashi, S., Takeda, T., Ogura, N., Jodo, S., Nakabayashi, T., et al. (1995). Up-regulated expression of Fas antigen (CD95) by peripheral naive and memory T cell subsets in patients with systemic lupus erythematosus (SLE): a possible mechanism for lymphopenia. Clin Exp Immunol, 99, 245-250.
32. Mohan, C., Adams, S., Stanik, V. and Datta, S. K. (1993). Nucleosome: a major immunogen for pathogenic autoantibody-inducing T cells of lupus. J. Exp. Med., 177, 1367-1381.
33. Casciola-Rosen, L., Rosen, A., Petri, M. and Schliessel, M. (1996). Surface blebs on apoptotic cells are sites of enhanced procoagulant activity: Implications for coagulation events and antigenic spread in systemic lupus erythematosus, Proc. Natl. Acad. Sci. USA, 93, 1624-1629.